Sciety offers capital market services with a focus on Swedish life science. Our services are based on extensive experience within health and hospital care, finance and entrepreneurship. Sciety selects investments in biotechnology, digital health, ICT in healthcare, pharmaceuticals and medical technology. Sciety focuses on Swedish companies with the goal to be acquired or listed within three years.
The companies’ capital requirements are between MSEK 10 and MSEK 100. The companies presented have been subjected to our extensive selection and review process where, among other things, business potential, medical relevance and legal documents are reviewed.